New Horizons in Translational Medicine

Add to Cart
New Horizons in Translational Medicine (NHTM) is the official publication of the http://www.eutranslationalmedicine.org/European Society for Translational Medicine. NHTM publishes high quality manuscripts covering all aspects of translational medicine. Special consideration is given to novel findings generated in cellular and molecular biology and omics disciplines. Moreover, high quality manuscripts describing novel developments in the field of biomarkers, disease modelling, big data mining and management are considered for publication. Along with original studies, focused reviews are also welcomed. Selection of papers for peer review and potential publication is based on their scientific excellence, distinctive contribution to knowledge (including methodological development) and their importance to the field.

Manuscript types NHTM

  • Research Articles (maximum of 7000 words)
  • Reviews (2,500 to 7,000 words)
  • News and Views
  • Meetings and Conferences Abstracts and Proceedings
  • Commentary
  • Commentaries can address hot topics which would be of interest to the translational medicine community. Commentaries can discuss scientific advances, healthcare policy issues, industry updates or other similar areas. Commentaries should be written in easy to understand format and with a maximum length of 6 pages. There is no limit for the references.

  • Perspectives
  • Perspectives are usually submissions which don?t fall under review or commentary categories. Prospective submissions should not exceed 3000 words and references should be limited to 80.

  • Correspondence or letter to the editor
  • Can briefly discuss research articles published anywhere or any other topic which would be of interest to the journal?s audience. This format can have a maximum of two pages with 15 references.